The Role of Clinical and Cost Information in Medicaid Pharmacy Benefit Decisions: Experience in Seven States
This policy brief provides perspective on the potential for using comparative effectiveness research in Medicaid pharmacy programs by looking at seven states to determine how they currently evaluate relative clinical and cost information about prescription drugs when making coverage decisions for their Medicaid pharmacy benefits. The brief was prepared by researchers at the Foundation’s Kaiser Commission on Medicaid and the Uninsured and Avalere Health.
Policy Brief (.pdf)
also of interest
- The Affordable Care Act's Impact on Medicaid Eligibility, Enrollment, and Benefits for People with Disabilities
- Medicare Part D Prescription Drug Plans: The Marketplace in 2013 and Key Trends, 2006-2013
- Analysis of Medicare Prescription Drug Plans In 2012 And Key Trends Since 2006
- Transparency and Complexity